These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12453987)

  • 41. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action.
    Peters EJ; Stuart CA; Prince MJ
    Metabolism; 1986 Sep; 35(9):807-13. PubMed ID: 3528742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acanthosis nigricans in pregnancy].
    Galasso F; Sbano E; Altamura V; Della Corte G
    G Ital Dermatol Venereol; 1989; 124(11-12):511-5. PubMed ID: 2700559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Case report: defective beta and alpha cell regulation in patients with hyperinsulinemia and acanthosis nigricans.
    Schuster D; O'Dorisio TM; Osei K
    Am J Med Sci; 1994 May; 307(5):342-5. PubMed ID: 8172227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
    Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
    Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Insulin receptors: biochemical and physiopathological aspects].
    Freychet P
    C R Seances Soc Biol Fil; 1984; 178(1):5-17. PubMed ID: 6234973
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin-specific binding to erythrocytes in 6 girls with acanthosis nigricans.
    Chaussain JL; Donnadieu M; Garagorri JM; Dupont C; Colle M; Leduc B
    Horm Res; 1984; 20(3):186-91. PubMed ID: 6489930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acanthosis nigricans: A fold (intertriginous) dermatosis.
    Kutlubay Z; Engin B; Bairamov O; Tüzün Y
    Clin Dermatol; 2015; 33(4):466-70. PubMed ID: 26051063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microscopic acanthosis nigricans in type 2 diabetes.
    McManus RM; Gottschalk R; Alanen K; Shum DT; Grundy P
    J Cutan Med Surg; 2001; 5(5):390-3. PubMed ID: 11907848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic basis of endocrine disease. 1. Molecular genetics of insulin resistant diabetes mellitus.
    Taylor SI; Cama A; Accili D; Barbetti F; Imano E; Kadowaki H; Kadowaki T
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1158-63. PubMed ID: 1955495
    [No Abstract]   [Full Text] [Related]  

  • 52. Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect.
    Bar RS; Muggeo M; Roth J; Kahn CR; Havrankova J; Imperato-McGinley J
    J Clin Endocrinol Metab; 1978 Sep; 47(3):620-5. PubMed ID: 400728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral muscle glucose and potassium transport in a family with acanthosis nigricans and insulin resistance.
    Saad MJ; Foss MC
    Braz J Med Biol Res; 1989; 22(6):683-6. PubMed ID: 2695195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review.
    Abraham C; Rozmus CL
    J Sch Nurs; 2012 Jun; 28(3):195-205. PubMed ID: 22179051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans.
    Cruz PD; Hud JA
    J Invest Dermatol; 1992 Jun; 98(6 Suppl):82S-85S. PubMed ID: 1316928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is this patient insulin resistant? How much does it matter?
    Sheeder J; Travers SH; Stevens-Simon C
    Clin Pediatr (Phila); 2003; 42(9):835-9. PubMed ID: 14686557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl with insulin resistance successfully treated with oral minocycline: Case report and published work review.
    Fukumoto T; Kozaru T; Sakaguchi M; Oka M
    J Dermatol; 2017 Aug; 44(8):954-958. PubMed ID: 28295566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes.
    Kobaissi HA; Weigensberg MJ; Ball GD; Cruz ML; Shaibi GQ; Goran MI
    Diabetes Care; 2004 Jun; 27(6):1412-6. PubMed ID: 15161797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations.
    Alatzoglou KS; Hindmarsh PC; Brain C; Torpiano J; Dattani MT
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3959-63. PubMed ID: 19622626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
    Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.